These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 8399655

  • 1. Relationship between plasma beta 2-microglobulin and residual diuresis in continuous ambulatory peritoneal dialysis and hemodialysis patients.
    Catizone L, Cocchi R, Fusaroli M, Zucchelli P.
    Perit Dial Int; 1993; 13 Suppl 2():S523-6. PubMed ID: 8399655
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [What does circulating beta 2 microglobulin signify in uremic patients on maintenance dialysis?].
    Assounga A, Canaud B, Flavier JL, Slingeneyer A, Robinet-Lévy M, Aznar R, Mion C.
    Nephrologie; 1987; 8(6):301-6. PubMed ID: 3330579
    [Abstract] [Full Text] [Related]

  • 6. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O, Stenvinkel P, Berglund L, Tranoeus A, Lindholm B.
    Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
    [Abstract] [Full Text] [Related]

  • 7. Continuous ambulatory peritoneal dialysis vs haemodialysis: a lesser risk of amyloidosis?
    Tielemans C, Dratwa M, Bergmann P, Goldman M, Flamion B, Collart F, Wens R.
    Nephrol Dial Transplant; 1988; 3(3):291-4. PubMed ID: 3140103
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Endothelin-1 in continuous ambulatory peritoneal dialysis and hemodialysis patients: a preliminary study.
    Lightfoot BO, Caruana RJ.
    Perit Dial Int; 1993; 13(1):55-8. PubMed ID: 8443279
    [Abstract] [Full Text] [Related]

  • 15. Influence of CAPD and residual diuresis on the serum levels of alpha-1-microglobulin in end-stage renal disease.
    Weber MH, Reetze P, Neumann F, Warneke G, Scheler F.
    Nephron; 1989; 51(3):367-9. PubMed ID: 2465498
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inflammatory effects of peritoneal dialysis: evidence of systemic monocyte activation.
    Libetta C, De Nicola L, Rampino T, De Simone W, Memoli B.
    Kidney Int; 1996 Feb; 49(2):506-11. PubMed ID: 8821837
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K, Stompór T, Gryz E, Szczudlik A, Drozdz M, Kraśniak A, Sułowicz W.
    Przegl Lek; 2007 Feb; 64(6):423-30. PubMed ID: 18159852
    [Abstract] [Full Text] [Related]

  • 19. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
    Al-Hweish A, Sultan SS, Mogazi K, Elsammak MY.
    Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
    [Abstract] [Full Text] [Related]

  • 20. [Serum beta 2-microglobulin concentration and its removal in patients treated with continuous ambulatory peritoneal dialysis].
    Kubo H, Kawaguchi Y, Aizawa S, Morita T, Nakayama M, Wakabayashi Y, Watanabe S, Ogawa A, Sakai O.
    Nihon Jinzo Gakkai Shi; 1990 Apr; 32(4):419-26. PubMed ID: 2198365
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.